# Use of Armodafinil for Fatigue in Sarcoidosis

> **NCT00555347** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 20 (actual)

## Conditions studied

- Sarcoidosis
- Fatigue
- Sleepiness

## Interventions

- **DRUG:** Armodafinil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00555347
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2010-08
- **Final completion:** 2011-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-05-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00555347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00555347, "Use of Armodafinil for Fatigue in Sarcoidosis". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00555347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*